Hoyeraal–Hreidarsson syndrome
Hoyeraal–Hreidarsson syndrome (HHS) is a rare, severe variant of Dyskeratosis congenita (DC), a disorder that can affect many parts of the body. HHS is characterized by cerebellar hypoplasia, severe immunodeficiency, intrauterine growth retardation, and microcephaly.
Symptoms[edit | edit source]
The symptoms of Hoyeraal–Hreidarsson syndrome include:
- Microcephaly: A condition where the head size is significantly smaller than that of other people of the same age and sex.
- Intrauterine growth retardation: This is a condition where a baby grows more slowly than normal during its time in the womb.
- Cerebellar hypoplasia: This is a neurological condition in which the cerebellum is smaller than usual or not completely developed.
- Severe immunodeficiency: This is a state where the immune system's ability to fight infectious disease and cancer is compromised or entirely absent.
Causes[edit | edit source]
Hoyeraal–Hreidarsson syndrome is caused by mutations in the DKC1, NOP10, NHP2, TERT, TCAB1, or TINF2 genes. These genes are involved in the maintenance of telomeres, which are structures found at the ends of chromosomes that protect them from damage.
Diagnosis[edit | edit source]
Diagnosis of Hoyeraal–Hreidarsson syndrome is based on the presence of characteristic symptoms and confirmed by genetic testing.
Treatment[edit | edit source]
Treatment of Hoyeraal–Hreidarsson syndrome is focused on managing the symptoms and may include bone marrow transplant for the bone marrow failure and immunodeficiency.
Prognosis[edit | edit source]
The prognosis for individuals with Hoyeraal–Hreidarsson syndrome is generally poor, with most individuals not surviving past childhood.
See also[edit | edit source]
- Dyskeratosis congenita
- Bone marrow transplant
- Microcephaly
- Intrauterine growth retardation
- Cerebellar hypoplasia
- Severe immunodeficiency
References[edit | edit source]
Hoyeraal–Hreidarsson syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD